Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
2026 will be a pivotal year for biopharma. From digital transformation to an AI ...
Understanding and overcoming these operational and economic hurdles is essential...
When we talk about “autonomous labs,” we are really talking about a new way to d...
Nick Edwards, PhD, CEO of Potato, has a “burning desire” to speed up scientific ...
The results of preclinical research indicate how T cells involved in the immune ...
On biopharma’s most visible stage, NVIDIA also showed how much of a key player i...
Illumina has launched the Billion Cell Atlas, a large‑scale CRISPR perturbation ...
The addition of K.F. will promote enhanced efforts to safeguard CRL’s supply cha...
Life-saving kidney failure treatment needs to come with mental health care too, ...
Combining an engineered HEK293 cell line containing inducible viral genes and so...
Researchers developed a ”living sensor display” engineered skin graft that funct...
The data demonstrate that the AutoCell platform can manufacture CGT with a 7-fol...
Pangenomics captures species-wide genetic variation, but current tools struggle ...
Trained on 9.7 trillion tokens, EDEN establishes a blueprint for scaling therape...
The largest single cell perturbation dataset to-date will be generated and relea...
Yeah, we know—it’s not a dire wolf. In early 2025, the Texas biotech company Col...
